Results 221 to 230 of about 584,999 (246)

The current state of molecular testing in the treatment of patients with solid tumors, 2019

Ca-A Cancer Journal for Clinicians, 2019
Wafik S El-Deiry, Richard M Goldberg, Heinz-Josef Lenz   +2 more
exaly  

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Ahmad A Tarhini
exaly  

Clinical evaluation of GP-41299). An anti-anxiety agent of the doxepine type.

, 1972
P Gaztanaga, Ruth Abrams, Jovan Simeon, Tushar Jones, Max Fink   +4 more
openalex  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
exaly  

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Comparative Study of Some Natural and Artificial Food Coloring Agents on Depression, Anxiety and Anti-Social Behavior in Weanling Rats

, 2015
Iosr Journals, Salwa K. El-Nabarawy, Omyma K. Radwan, Suzan F. El-Sisi, Areeg Abd‐Elrazek   +4 more
openalex   +2 more sources

[Neurochemical characteristics of the ventromedial hypothalamus and anti-aversive effects of anxiolytic agents in various anxiety models].

, 2001
Talalaenko An, Pankrat'ev Dv, Goncharenko Nv   +2 more
openalex  

Intramuscular diazepam as anti-anxiety agent in SCC-modified EST.

, 1969
Rousos Ap, Ralph J. Hazlewood, Orr R
openalex  

Fluphenazine dihydrochloride--an anti-anxiety agent.

, 1962
Edwin Dunlop
openalex